Conventus Orthopedics (Minneapolis), a privately held company focused on revolutionizing treatment for peri-articular fractures, has received FDA clearance to market its Conventus DRS Implant for the treatment of distal radius fractures within the U.S. The Conventus DRS Implant is designed to provide a less invasive means for orthopedic surgeons to treat patients with distal radius fractures, returning them to normal daily activities sooner and with less pain.

A partnership between two companies has led to the development of an autonomous robotic system, which could have the potential to significantly make the jobs of physicians and clinicians a bit easier.

Selventa (Cambridge, Massachusetts) reported that it plans to introduce a new class of diagnostic test that would promote personalized healthcare technologies.

In a move to strengthen its presence in emerging markets, Stryker (Kalamazoo, Michigan) reported that it will make a voluntary general offer to acquire all the shares of Trauson Holdings (Hong Kong), a firm that specializes in products for the spine, for $764 million in an all cash transaction.